Jaime S. King, J.D., Ph.D.
doi : 10.1056/NEJMp2201629
Vol. 388 No. 12
Sara Rosenbaum, J.D., Sara R. Collins, Ph.D., MaryBeth Musumeci, J.D., and Alex Somodevilla, J.D.
doi : 10.1056/NEJMp2301021
Eric J. Lenze, M.D., Benoit H. Mulsant, M.D., Steven P. Roose, M.D., Helen Lavretsky, M.D., Charles F. Reynolds, III, M.D., Daniel M. Blumberger, M.D., Patrick J. Brown, Ph.D., Pilar Cristancho, M.D., Alastair J. Flint, M.B., Marie A. Gebara, M.D., Torie R. Gettinger, Ph.D., Emily Lenard, M.S.W., J. Philip Miller, A.B., Ginger E. Nicol, M.D., Hanadi A. Oughli, M.D., Vy T. Pham, M.D., M.P.H., Bruce L. Rollman, M.D., M.P.H., Lei Yang, M.P.H., M.S.I.S., and Jordan F. Karp, M.D.
doi : 10.1056/NEJMoa2204462
The benefits and risks of augmenting or switching antidepressants in older adults with treatment-resistant depression have not been extensively studied.
Jonathan I. Silverberg, M.D., Ph.D., M.P.H, Emma Guttman-Yassky, M.D., Ph.D., Diamant Thaçi, M.D., Alan D. Irvine, M.D., Linda Stein Gold, M.D., Andrew Blauvelt, M.D., Eric L. Simpson, M.D., Chia-Yu Chu, M.D., Ph.D., Zhuqing Liu, Ph.D., Renata Gontijo Lima, M.D., Sreekumar G. Pillai, Ph.D., and Julien Seneschal, M.D., Ph.D. for the ADvocate1 and ADvocate2 Investigators*
doi : 10.1056/NEJMoa2206714
Lebrikizumab, a high-affinity IgG4 monoclonal antibody targeting interleukin-13, prevents the formation of the interleukin-4Rα–interleukin-13Rα1 heterodimer receptor signaling complex.
Gregory M. Marcus, M.D., David G. Rosenthal, M.D., Gregory Nah, M.S., Eric Vittinghoff, Ph.D., Christina Fang, B.A., Kelsey Ogomori, B.S., Sean Joyce, Sc.B., Defne Yilmaz, M.S., Vivian Yang, B.A., Tara Kessedjian, Emily Wilson, B.S., Michelle Yang, B.S., Kathleen Chang, B.S., Grace Wall, B.A., and Jeffrey E. Olgin, M.D.
doi : 10.1056/NEJMoa2204737
Coffee is one of the most commonly consumed beverages in the world, but the acute health effects of coffee consumption remain uncertain.
Brian E. McGarry, P.T., Ph.D., Ashvin D. Gandhi, Ph.D., and Michael L. Barnett, M.D.
doi : 10.1056/NEJMoa2210063
Despite widespread adoption of surveillance testing for coronavirus disease 2019 (Covid-19) among staff members in skilled nursing facilities, evidence is limited regarding its relationship with outcomes among facility residents.
Brian A. Houston, M.D., Evan L. Brittain, M.D., and Ryan J. Tedford, M.D.
doi : 10.1056/NEJMra2207410
Rojita Akham, M.B., B.S., and Neirita Hazarika, M.D.
doi : 10.1056/NEJMicm2210124
Chin-Chean Wong, M.D., Ph.D., and Bing-Kuan Chen, M.D.
doi : 10.1056/NEJMicm2209948
Shaun F. Fitzgerald, M.D., M.P.H., Teresa Victoria, M.D., Ph.D., Weizhen Tan, M.D., and Cynthia K. Harris, M.D.
doi : 10.1056/NEJMcpc2211356
Gemma Lewis, Ph.D., and Glyn Lewis, Ph.D.
doi : 10.1056/NEJMe2301045
Kathleen M. Neuzil, M.D., M.P.H.
doi : 10.1056/NEJMcibr2215281
doi : 10.1056/NEJMc2300338
Do you want to add Medilib to your home screen?